Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic CancerEric Van Cutsem, Malcolm J. Moore, Jean‐Luc Van Laethem et al.|Journal of Clinical Oncology|2009Cited by 643
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (AVANT): a phase 3 randomised controlled trialAimery de Gramont, Paulo M. Hoff, Eric Van Cutsem et al.|The Lancet Oncology|2012Cited by 526
GetReal in network meta‐analysis: a review of the methodologyOrestis Efthimiou, Thomas P. A. Debray, Gert van Valkenhoef et al.|Research Synthesis Methods|2016Cited by 415